▶ 調査レポート

JAK及びPI3K信号経路の世界市場 2020年

• 英文タイトル:Global JAK and PI3K Signaling Pathway Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。JAK及びPI3K信号経路の世界市場 2020年 / Global JAK and PI3K Signaling Pathway Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / GIR201115741資料のイメージです。• レポートコード:GIR201115741
• 出版社/出版日:GlobalInfoResearch / 2020年10月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥508,080 (USD3,480)▷ お問い合わせ
  Multi User¥762,120 (USD5,220)▷ お問い合わせ
  Corporate User¥1,016,160 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、JAK及びPI3K信号経路の世界市場を調査対象にし、JAK及びPI3K信号経路の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(PI3K、ヤヌスキナーゼ療法(阻害剤)、PI3K療法(阻害剤)、JAK及びPI3Kシグナル伝達バイオマーカー)、用途別分析(がん、炎症性疾患、心臓病、その他)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Bayer HealthCare Pharmaceuticals、Infinity Pharmaceuticals、Curis、AbbVie、Genentech、AstraZeneca、Rigel Pharmaceuticals、Exelixis、Daiichi Sankyo、Merck & Co.、TG Therapeutics、WILEX AG、Sanofi Oncology、Vertex Pharmaceuticals
・企業別売上、市場シェア
・JAK及びPI3K信号経路の地域別市場分析
・JAK及びPI3K信号経路の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・JAK及びPI3K信号経路のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・JAK及びPI3K信号経路のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・JAK及びPI3K信号経路の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・JAK及びPI3K信号経路の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・JAK及びPI3K信号経路の種類別市場規模2015-2020:PI3K、ヤヌスキナーゼ療法(阻害剤)、PI3K療法(阻害剤)、JAK及びPI3Kシグナル伝達バイオマーカー
・JAK及びPI3K信号経路の用途別市場規模2015-2020:がん、炎症性疾患、心臓病、その他
・JAK及びPI3K信号経路の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The global JAK and PI3K Signaling Pathway market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The JAK and PI3K Signaling Pathway market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
JAK and PI3K Signaling Pathway market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, JAK and PI3K Signaling Pathway market has been segmented into:
PI3K
Janus Kinase Therapies (Inhibitors)
PI3K Therapies (Inhibitors)
Signal Transduction Biomarkers for JAK and PI3K

By Application, JAK and PI3K Signaling Pathway has been segmented into:
Cancer
Inflammatory Diseases
Cardiac Ailments
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global JAK and PI3K Signaling Pathway market presented in the report. This section sheds light on the sales growth of different regional and country-level JAK and PI3K Signaling Pathway markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global JAK and PI3K Signaling Pathway market.

The report offers in-depth assessment of the growth and other aspects of the JAK and PI3K Signaling Pathway market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and JAK and PI3K Signaling Pathway Market Share Analysis
JAK and PI3K Signaling Pathway competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, JAK and PI3K Signaling Pathway sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the JAK and PI3K Signaling Pathway sales, revenue and market share for each player covered in this report.

The major players covered in JAK and PI3K Signaling Pathway are:
Bayer HealthCare Pharmaceuticals
Infinity Pharmaceuticals
Curis
AbbVie
Genentech
AstraZeneca
Rigel Pharmaceuticals
Exelixis
Daiichi Sankyo
Merck & Co.
TG Therapeutics
WILEX AG
Sanofi Oncology
Vertex Pharmaceuticals

レポート目次

Table of Contents

1 JAK and PI3K Signaling Pathway Market Overview
1.1 Product Overview and Scope of JAK and PI3K Signaling Pathway
1.2 Classification of JAK and PI3K Signaling Pathway by Type
1.2.1 Global JAK and PI3K Signaling Pathway Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global JAK and PI3K Signaling Pathway Revenue Market Share by Type in 2019
1.2.3 PI3K
1.2.4 Janus Kinase Therapies (Inhibitors)
1.2.5 PI3K Therapies (Inhibitors)
1.2.6 Signal Transduction Biomarkers for JAK and PI3K
1.3 Global JAK and PI3K Signaling Pathway Market by Application
1.3.1 Overview: Global JAK and PI3K Signaling Pathway Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Inflammatory Diseases
1.3.4 Cardiac Ailments
1.3.5 Others
1.4 Global JAK and PI3K Signaling Pathway Market by Regions
1.4.1 Global JAK and PI3K Signaling Pathway Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of JAK and PI3K Signaling Pathway (2015-2025)
1.4.3 North America (USA, Canada and Mexico) JAK and PI3K Signaling Pathway Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) JAK and PI3K Signaling Pathway Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) JAK and PI3K Signaling Pathway Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) JAK and PI3K Signaling Pathway Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) JAK and PI3K Signaling Pathway Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bayer HealthCare Pharmaceuticals
2.1.1 Bayer HealthCare Pharmaceuticals Details
2.1.2 Bayer HealthCare Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer HealthCare Pharmaceuticals SWOT Analysis
2.1.4 Bayer HealthCare Pharmaceuticals Product and Services
2.1.5 Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.2 Infinity Pharmaceuticals
2.2.1 Infinity Pharmaceuticals Details
2.2.2 Infinity Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Infinity Pharmaceuticals SWOT Analysis
2.2.4 Infinity Pharmaceuticals Product and Services
2.2.5 Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.3 Curis
2.3.1 Curis Details
2.3.2 Curis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Curis SWOT Analysis
2.3.4 Curis Product and Services
2.3.5 Curis JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AbbVie SWOT Analysis
2.4.4 AbbVie Product and Services
2.4.5 AbbVie JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.5 Genentech
2.5.1 Genentech Details
2.5.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Genentech SWOT Analysis
2.5.4 Genentech Product and Services
2.5.5 Genentech JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.7 Rigel Pharmaceuticals
2.7.1 Rigel Pharmaceuticals Details
2.7.2 Rigel Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Rigel Pharmaceuticals SWOT Analysis
2.7.4 Rigel Pharmaceuticals Product and Services
2.7.5 Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.8 Exelixis
2.8.1 Exelixis Details
2.8.2 Exelixis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Exelixis SWOT Analysis
2.8.4 Exelixis Product and Services
2.8.5 Exelixis JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.9 Daiichi Sankyo
2.9.1 Daiichi Sankyo Details
2.9.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Daiichi Sankyo SWOT Analysis
2.9.4 Daiichi Sankyo Product and Services
2.9.5 Daiichi Sankyo JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck & Co.
2.10.1 Merck & Co. Details
2.10.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck & Co. SWOT Analysis
2.10.4 Merck & Co. Product and Services
2.10.5 Merck & Co. JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.11 TG Therapeutics
2.11.1 TG Therapeutics Details
2.11.2 TG Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 TG Therapeutics SWOT Analysis
2.11.4 TG Therapeutics Product and Services
2.11.5 TG Therapeutics JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.12 WILEX AG
2.12.1 WILEX AG Details
2.12.2 WILEX AG Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 WILEX AG SWOT Analysis
2.12.4 WILEX AG Product and Services
2.12.5 WILEX AG JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sanofi Oncology
2.13.1 Sanofi Oncology Details
2.13.2 Sanofi Oncology Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Sanofi Oncology SWOT Analysis
2.13.4 Sanofi Oncology Product and Services
2.13.5 Sanofi Oncology JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
2.14 Vertex Pharmaceuticals
2.14.1 Vertex Pharmaceuticals Details
2.14.2 Vertex Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Vertex Pharmaceuticals SWOT Analysis
2.14.4 Vertex Pharmaceuticals Product and Services
2.14.5 Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global JAK and PI3K Signaling Pathway Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 JAK and PI3K Signaling Pathway Players Market Share
3.2.2 Top 10 JAK and PI3K Signaling Pathway Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global JAK and PI3K Signaling Pathway Revenue and Market Share by Regions
4.2 North America JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
4.3 Europe JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
4.5 South America JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
5 North America JAK and PI3K Signaling Pathway Revenue by Countries
5.1 North America JAK and PI3K Signaling Pathway Revenue by Countries (2015-2020)
5.2 USA JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
5.3 Canada JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
5.4 Mexico JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
6 Europe JAK and PI3K Signaling Pathway Revenue by Countries
6.1 Europe JAK and PI3K Signaling Pathway Revenue by Countries (2015-2020)
6.2 Germany JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
6.3 UK JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
6.4 France JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
6.5 Russia JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
6.6 Italy JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
7 Asia-Pacific JAK and PI3K Signaling Pathway Revenue by Countries
7.1 Asia-Pacific JAK and PI3K Signaling Pathway Revenue by Countries (2015-2020)
7.2 China JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
7.3 Japan JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
7.4 Korea JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
7.5 India JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
8 South America JAK and PI3K Signaling Pathway Revenue by Countries
8.1 South America JAK and PI3K Signaling Pathway Revenue by Countries (2015-2020)
8.2 Brazil JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
8.3 Argentina JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue JAK and PI3K Signaling Pathway by Countries
9.1 Middle East & Africa JAK and PI3K Signaling Pathway Revenue by Countries (2015-2020)
9.2 Saudi Arabia JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
9.3 UAE JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
9.4 Egypt JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
9.5 South Africa JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global JAK and PI3K Signaling Pathway Revenue and Market Share by Type (2015-2020)
10.2 Global JAK and PI3K Signaling Pathway Market Forecast by Type (2019-2024)
10.3 PI3K Revenue Growth Rate (2015-2025)
10.4 Janus Kinase Therapies (Inhibitors) Revenue Growth Rate (2015-2025)
10.5 PI3K Therapies (Inhibitors) Revenue Growth Rate (2015-2025)
10.6 Signal Transduction Biomarkers for JAK and PI3K Revenue Growth Rate (2015-2025)
11 Global JAK and PI3K Signaling Pathway Market Segment by Application
11.1 Global JAK and PI3K Signaling Pathway Revenue Market Share by Application (2015-2020)
11.2 JAK and PI3K Signaling Pathway Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Inflammatory Diseases Revenue Growth (2015-2020)
11.5 Cardiac Ailments Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global JAK and PI3K Signaling Pathway Market Size Forecast (2021-2025)
12.1 Global JAK and PI3K Signaling Pathway Market Size Forecast (2021-2025)
12.2 Global JAK and PI3K Signaling Pathway Market Forecast by Regions (2021-2025)
12.3 North America JAK and PI3K Signaling Pathway Revenue Market Forecast (2021-2025)
12.4 Europe JAK and PI3K Signaling Pathway Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific JAK and PI3K Signaling Pathway Revenue Market Forecast (2021-2025)
12.6 South America JAK and PI3K Signaling Pathway Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa JAK and PI3K Signaling Pathway Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global JAK and PI3K Signaling Pathway Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of JAK and PI3K Signaling Pathway by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global JAK and PI3K Signaling Pathway Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market JAK and PI3K Signaling Pathway Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bayer HealthCare Pharmaceuticals Corporate Information, Location and Competitors
Table 6. Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Major Business
Table 7. Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 8. Bayer HealthCare Pharmaceuticals SWOT Analysis
Table 9. Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Product and Solutions
Table 10. Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Infinity Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Major Business
Table 13. Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2018-2019)
Table 14. Infinity Pharmaceuticals SWOT Analysis
Table 15. Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Product and Solutions
Table 16. Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Curis Corporate Information, Location and Competitors
Table 18. Curis JAK and PI3K Signaling Pathway Major Business
Table 19. Curis JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 20. Curis SWOT Analysis
Table 21. Curis JAK and PI3K Signaling Pathway Product and Solutions
Table 22. Curis JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AbbVie Corporate Information, Location and Competitors
Table 24. AbbVie JAK and PI3K Signaling Pathway Major Business
Table 25. AbbVie JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 26. AbbVie SWOT Analysis
Table 27. AbbVie JAK and PI3K Signaling Pathway Product and Solutions
Table 28. AbbVie JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Genentech Corporate Information, Location and Competitors
Table 30. Genentech JAK and PI3K Signaling Pathway Major Business
Table 31. Genentech JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 32. Genentech SWOT Analysis
Table 33. Genentech JAK and PI3K Signaling Pathway Product and Solutions
Table 34. Genentech JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AstraZeneca Corporate Information, Location and Competitors
Table 36. AstraZeneca JAK and PI3K Signaling Pathway Major Business
Table 37. AstraZeneca JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 38. AstraZeneca SWOT Analysis
Table 39. AstraZeneca JAK and PI3K Signaling Pathway Product and Solutions
Table 40. AstraZeneca JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Rigel Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Major Business
Table 43. Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 44. Rigel Pharmaceuticals SWOT Analysis
Table 45. Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Product and Solutions
Table 46. Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Exelixis Corporate Information, Location and Competitors
Table 48. Exelixis JAK and PI3K Signaling Pathway Major Business
Table 49. Exelixis JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 50. Exelixis SWOT Analysis
Table 51. Exelixis JAK and PI3K Signaling Pathway Product and Solutions
Table 52. Exelixis JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Daiichi Sankyo Corporate Information, Location and Competitors
Table 54. Daiichi Sankyo JAK and PI3K Signaling Pathway Major Business
Table 55. Daiichi Sankyo JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 56. Daiichi Sankyo SWOT Analysis
Table 57. Daiichi Sankyo JAK and PI3K Signaling Pathway Product and Solutions
Table 58. Daiichi Sankyo JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Merck & Co. Corporate Information, Location and Competitors
Table 60. Merck & Co. JAK and PI3K Signaling Pathway Major Business
Table 61. Merck & Co. JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 62. Merck & Co. SWOT Analysis
Table 63. Merck & Co. JAK and PI3K Signaling Pathway Product and Solutions
Table 64. Merck & Co. JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. TG Therapeutics Corporate Information, Location and Competitors
Table 66. TG Therapeutics JAK and PI3K Signaling Pathway Major Business
Table 67. TG Therapeutics JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 68. TG Therapeutics SWOT Analysis
Table 69. TG Therapeutics JAK and PI3K Signaling Pathway Product and Solutions
Table 70. TG Therapeutics JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. WILEX AG Corporate Information, Location and Competitors
Table 72. WILEX AG JAK and PI3K Signaling Pathway Major Business
Table 73. WILEX AG JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 74. WILEX AG SWOT Analysis
Table 75. WILEX AG JAK and PI3K Signaling Pathway Product and Solutions
Table 76. WILEX AG JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Sanofi Oncology Corporate Information, Location and Competitors
Table 78. Sanofi Oncology JAK and PI3K Signaling Pathway Major Business
Table 79. Sanofi Oncology JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 80. Sanofi Oncology SWOT Analysis
Table 81. Sanofi Oncology JAK and PI3K Signaling Pathway Product and Solutions
Table 82. Sanofi Oncology JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Vertex Pharmaceuticals Corporate Information, Location and Competitors
Table 84. Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Major Business
Table 85. Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Total Revenue (USD Million) (2017-2018)
Table 86. Vertex Pharmaceuticals SWOT Analysis
Table 87. Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Product and Solutions
Table 88. Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global JAK and PI3K Signaling Pathway Revenue (Million USD) by Players (2015-2020)
Table 90. Global JAK and PI3K Signaling Pathway Revenue Share by Players (2015-2020)
Table 91. Global JAK and PI3K Signaling Pathway Revenue (Million USD) by Regions (2015-2020)
Table 92. Global JAK and PI3K Signaling Pathway Revenue Market Share by Regions (2015-2020)
Table 93. North America JAK and PI3K Signaling Pathway Revenue by Countries (2015-2020)
Table 94. North America JAK and PI3K Signaling Pathway Revenue Market Share by Countries (2015-2020)
Table 95. Europe JAK and PI3K Signaling Pathway Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific JAK and PI3K Signaling Pathway Revenue (Million USD) by Countries (2015-2020)
Table 97. South America JAK and PI3K Signaling Pathway Revenue by Countries (2015-2020)
Table 98. South America JAK and PI3K Signaling Pathway Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa JAK and PI3K Signaling Pathway Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa JAK and PI3K Signaling Pathway Revenue Market Share by Countries (2015-2020)
Table 101. Global JAK and PI3K Signaling Pathway Revenue (Million USD) by Type (2015-2020)
Table 102. Global JAK and PI3K Signaling Pathway Revenue Share by Type (2015-2020)
Table 103. Global JAK and PI3K Signaling Pathway Revenue Forecast by Type (2021-2025)
Table 104. Global JAK and PI3K Signaling Pathway Revenue by Application (2015-2020)
Table 105. Global JAK and PI3K Signaling Pathway Revenue Share by Application (2015-2020)
Table 106. Global JAK and PI3K Signaling Pathway Revenue Forecast by Application (2021-2025)
Table 107. Global JAK and PI3K Signaling Pathway Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. JAK and PI3K Signaling Pathway Picture
Figure 2. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type in 2019
Figure 3. PI3K Picture
Figure 4. Janus Kinase Therapies (Inhibitors) Picture
Figure 5. PI3K Therapies (Inhibitors) Picture
Figure 6. Signal Transduction Biomarkers for JAK and PI3K Picture
Figure 7. JAK and PI3K Signaling Pathway Revenue Market Share by Application in 2019
Figure 8. Cancer Picture
Figure 9. Inflammatory Diseases Picture
Figure 10. Cardiac Ailments Picture
Figure 11. Others Picture
Figure 12. Global JAK and PI3K Signaling Pathway Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America JAK and PI3K Signaling Pathway Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe JAK and PI3K Signaling Pathway Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific JAK and PI3K Signaling Pathway Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America JAK and PI3K Signaling Pathway Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa JAK and PI3K Signaling Pathway Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global JAK and PI3K Signaling Pathway Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global JAK and PI3K Signaling Pathway Revenue Share by Players in 2019
Figure 20. Global Top 5 Players JAK and PI3K Signaling Pathway Revenue Market Share in 2019
Figure 21. Global Top 10 Players JAK and PI3K Signaling Pathway Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global JAK and PI3K Signaling Pathway Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global JAK and PI3K Signaling Pathway Revenue Market Share by Regions (2015-2020)
Figure 25. Global JAK and PI3K Signaling Pathway Revenue Market Share by Regions in 2018
Figure 26. North America JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 27. Europe JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 29. South America JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 31. North America JAK and PI3K Signaling Pathway Revenue Market Share by Countries (2015-2020)
Figure 32. North America JAK and PI3K Signaling Pathway Revenue Market Share by Countries in 2019
Figure 33. USA JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 34. Canada JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 35. Mexico JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 36. Europe JAK and PI3K Signaling Pathway Revenue Market Share by Countries (2015-2020)
Figure 37. Europe JAK and PI3K Signaling Pathway Revenue Market Share by Countries in 2019
Figure 38. Germany JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 39. UK JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 40. France JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 41. Russia JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 42. Italy JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific JAK and PI3K Signaling Pathway Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific JAK and PI3K Signaling Pathway Revenue Market Share by Countries in 2019
Figure 45. China JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 46. Japan JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 47. Korea JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 48. India JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 50. South America JAK and PI3K Signaling Pathway Revenue Market Share by Countries (2015-2020)
Figure 51. South America JAK and PI3K Signaling Pathway Revenue Market Share by Countries in 2019
Figure 52. Brazil JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 53. Argentina JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa JAK and PI3K Signaling Pathway Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa JAK and PI3K Signaling Pathway Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 57. UAE JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 58. Egypt JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 59. South Africa JAK and PI3K Signaling Pathway Revenue and Growth Rate (2015-2020)
Figure 60. Global JAK and PI3K Signaling Pathway Revenue Share by Type (2015-2020)
Figure 61. Global JAK and PI3K Signaling Pathway Revenue Share by Type in 2019
Figure 62. Global JAK and PI3K Signaling Pathway Market Share Forecast by Type (2021-2025)
Figure 63. Global PI3K Revenue Growth Rate (2015-2020)
Figure 64. Global Janus Kinase Therapies (Inhibitors) Revenue Growth Rate (2015-2020)
Figure 65. Global PI3K Therapies (Inhibitors) Revenue Growth Rate (2015-2020)
Figure 66. Global Signal Transduction Biomarkers for JAK and PI3K Revenue Growth Rate (2015-2020)
Figure 67. Global JAK and PI3K Signaling Pathway Revenue Share by Application (2015-2020)
Figure 68. Global JAK and PI3K Signaling Pathway Revenue Share by Application in 2019
Figure 69. Global JAK and PI3K Signaling Pathway Market Share Forecast by Application (2021-2025)
Figure 70. Global Cancer Revenue Growth Rate (2015-2020)
Figure 71. Global Inflammatory Diseases Revenue Growth Rate (2015-2020)
Figure 72. Global Cardiac Ailments Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global JAK and PI3K Signaling Pathway Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global JAK and PI3K Signaling Pathway Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global JAK and PI3K Signaling Pathway Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America JAK and PI3K Signaling Pathway Revenue Market Forecast (2021-2025)
Figure 78. Europe JAK and PI3K Signaling Pathway Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific JAK and PI3K Signaling Pathway Revenue Market Forecast (2021-2025)
Figure 80. South America JAK and PI3K Signaling Pathway Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa JAK and PI3K Signaling Pathway Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel